Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesca.bufalieri@uniroma1.it
Francesca Bufalieri
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
francesca.bufalieri@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation
ONCOGENE
2024
Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation
CANCER LETTERS
2023
SALL4 is a CRL3^REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma
CELL DEATH AND DIFFERENTIATION
2023
ERAP1 as an emerging therapeutic target for medulloblastoma
TRENDS IN CANCER
2022
Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2022
A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma
NEUROPATHOLOGY & APPLIED NEUROBIOLOGY
2022
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma
CANCER LETTERS
2021
Harnessing the activation of RIG-I like receptors to inhibit glioblastoma tumorigenesis
FRONTIERS IN MOLECULAR NEUROSCIENCE
2021
The rna-binding ubiquitin ligase mex3a affects glioblastoma tumorigenesis by inducing ubiquitylation and degradation of rig-i
CANCERS
2020
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
EXPERT OPINION ON THERAPEUTIC TARGETS
2020
Dual smo/braf inhibition by flavonolignans from silybum marianum†
ANTIOXIDANTS
2020
Dubs activating the hedgehog signaling pathway: a promising therapeutic target in cancer
CANCERS
2020
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP
NATURE COMMUNICATIONS
2019
Targeting hedgehog signalling through the ubiquitylation process: the multiple roles of the HECT-E3 ligase itch
CELLS
2019
A Smo/Gli multitarget hedgehog pathway inhibitor impairs tumor growth
CANCERS
2019
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis
NATURE COMMUNICATIONS
2018
Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.
SCIENTIFIC REPORTS
2017
Maml1 acts cooperatively with Gli proteins to regulate Sonic hedgheog signaling pathway
CELL DEATH & DISEASE
2017
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
SCIENTIFIC REPORTS
2017
Progetti di Ricerca
Understanding the role of the E3 ubiquitin ligase TRIM21 in the Hedgehog pathway control and Hedgehog-dependent tumorigenesis.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma